Oral Oncology
Volume 38, Issue 1 , Pages 6-15, January 2002

Mapping of the candidate tumor suppressor genes’ loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population

  • S Dasgupta

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Calcutta 700026, India
  • ,
  • N Mukherjee

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Calcutta 700026, India
  • ,
  • S Roy

      Affiliations

    • Department of Human Genetics, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Calcutta 700032, India
  • ,
  • A Roy

      Affiliations

    • Department of Pathology, Medical College and Hospital, Calcutta 700073, India
  • ,
  • A Sengupta

      Affiliations

    • Cancer Center and Welfare Home, Calcutta 700063, India
  • ,
  • S Roychowdhury

      Affiliations

    • Department of Human Genetics, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Calcutta 700032, India
  • ,
  • C.K Panda

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Calcutta 700026, India
    • Corresponding Author InformationCorresponding author. Tel.: +91-33-476-5101, ext. 328; fax: +91-33-475-7606

Received 26 August 2000; accepted 13 November 2000.

Abstract 

The candidate tumor suppressor genes’ (TSG) loci on human chromosome 3 (chr.3) were mapped in six dysplastic lesions and 51 primary squamous cell carcinoma from head and neck region of an Indian patient population by using 20 highly polymorphic microsatellite markers. The two chromosomal regions 3p12-13 and 3p21.2-22 have shown the highest losses of heterozygosity (LOHs) of 34.6–38% and 37–46%, respectively with statistically significant clinical correlation’s with tobacco habit, positive lymph node and tumor stages. In addition, high frequencies of microsatellite size alterations (MAs) of 16.2–28.5% and 23.8–28.2% were observed in the chromosomal 3p11-13 and 3p21.2-22 regions, respectively, with significant above-mentioned clinical correlation only in the 3p11-13 region. In the dysplastic lesions, the prevalence of LOHs compared to the MAs had indicated that LOHs might be the early events. Five tumors at stage-III/IV seemed to have lost an entire normal copy of chr.3. It was of particular note that 17% (10/57) of the samples showed rare bi-allelic alterations mainly in and around the high LOHs regions. Thus, (1) the gradual increase of LOHs/MAs during progression of the tumor, (2) high frequencies of MAs, (3) rare bi-allelic alterations in and around high LOHs regions and (4) loss of wild type chr.3 in the later stages of tumor development have suggested that such alterations might provide selective growth advantage to the tumors. Also, we propose from our data that the high LOHs regions (3p12-13 and 3p21.2-22) could harbour putative TSG(s), responsible for the development of head and neck squamous cell carcinoma.

Keywords:  Head and neck squamous cell carcinoma, Chromosome 3, Tumor suppressor gene (s), Loss of heterozygosity, Microsatellite size alteration

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(00)00131-7

Oral Oncology
Volume 38, Issue 1 , Pages 6-15, January 2002